Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203567 · ClinicalTrials.gov registry record · Phase 4
Carbamazepine Extended-Release for the Treatment of Bipolar Depression
A Phase 4 study, sponsored by Tuscaloosa Research & Education Advancement Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT00203567 is a Phase 4 study that has completed, run by Tuscaloosa Research & Education Advancement Corporation. The registered enrollment target is 25 participants.
The verdict
NCT00203567, a Phase 4 study, has completed, sponsored by Tuscaloosa Research & Education Advancement Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
To study the efficacy and safety of beaded extended-release Carbamazepine (Equetro) in the treatment of patients with Bipolar Disorder with a Major Depressive Episode.
Interventions
- DRUG carbamazepine ER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00203567
The ClinicalTrials.gov registry entry for NCT00203567 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tuscaloosa Research & Education Advancement Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which carbamazepine ER is the first listed.
NCT00203567 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00203567 about?
NCT00203567 is a clinical study titled "Carbamazepine Extended-Release for the Treatment of Bipolar Depression". To study the efficacy and safety of beaded extended-release Carbamazepine (Equetro) in the treatment of patients with Bipolar Disorder with a Major Depressive Episode.
What is the current status of trial NCT00203567?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2005-08. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00203567?
The interventions under investigation include: carbamazepine ER (DRUG).
Who is sponsoring clinical trial NCT00203567?
This trial is sponsored by Tuscaloosa Research & Education Advancement Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.